Pharmaceutical biotechnology is the application of biotechnological methods to obtain products from animal, plant and microbial organisms or parts thereof. In pharmaceutical research, the term "biological products" usually refers to blood-derived drugs, vaccines, toxins, and allergens, while "biotechnological products" has a much broader and deeper meaning. Basically, the term refers to the use of biological systems (e.g., cells or tissues) or biological molecules (e.g., enzymes or antibodies) to produce commercial products. While biopharmaceuticals or biotechnology products are considered to be genetically engineered proteins that are already approved or under development, in recent years these terms have also come to include nucleic acid-based products, i.e., products based on deoxyribonucleic acid (DNA) or ribonucleic acid (RNA), as well as whole cell-based products.
The design of new therapeutic drugs, the development of diagnostics for medical tests, gene therapy, recombinant DNA technology, the production and formulation of peptides and proteins, DNA vaccines, monoclonal antibodies and their carrier systems are the main areas of research in pharmaceutical biotechnology.
The courses currently offered by the Department of Pharmaceutical Biotechnology are;
Recombinant DNA Techniques,